Skip to content

Prehospital recognition and antibiotics for 999 patients with severe sepsis

Prehospital Recognition and Antibiotics for 999 patients with Severe sepsis (PHRASE): a feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36856873
Enrollment
100
Registered
2017-05-24
Start date
2017-11-01
Completion date
Unknown
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis Infections and Infestations Sepsis, unspecified

Interventions

Sixty paramedics will be recruited to the study and will receive an enhanced level of training to assist them to recognise severe sepsis. If severe 'Red Flag’ sepsis is suspected, paramedics will sele

Sponsors

Wales Ambulance Services NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients 18 years of age and above 2. Attended by study paramedics 3. Identified as 'Red Flag’ sepsis 4. Admitted to participating hospital

Exclusion criteria

Exclusion criteria: 1. Pregnancy (known or suspected) 2. Known history of allergy to antibiotics

Design outcomes

Primary

MeasureTime frame
The feasibility of undertaking a randomised controlled trial (RCT) to test the clinical and cost-effectiveness of paramedics providing IV antibiotics as early treatment for patients with severe sepsis. The trialists will assess whether or not to proceed to a full multi-site RCT based on the following progression criteria: 1. 60% of the 100 eligible paramedics agree to take part in the study 2. 70% of eligible patients consent to take part in the study 3. Follow-up data for potential primary outcomes can be collected for 70% or more of patients at 90 days 4. Mean patient satisfaction in intervention group is not less than 80% of patient satisfaction in the control group 5. Feasibility trial findings indicate that they remain in equipoise about the effectiveness of paramedic collection of blood cultures and antibiotic administration (i.e. that delivery of the intervention does not exceed a greater than 20-minute difference in on-scene times for patients compared to those in the control group) 6. Adverse event rate (e.g. allergic (anaphylactic) reactions to antibiotics) of less than 5%

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom, Wales

Contacts

Public ContactJenna Bulger
j.k.bulger@swansea.ac.uk+44 (0)179 251 3424

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026